Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -62.15% is 59% above its 5-year average of -152.51%, near the high end of its 5-year range (-496.41%–-36.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.67% above its 12-month average of -101.35%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -62.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-62.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-101.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-188.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-152.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.67%
CURRENT VS 3Y AVG
+67.08%
CURRENT VS 5Y AVG
+59.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-74.37%
vs the sector median at left
Unicycive Therapeutics, Inc.
Market Cap
$111.35M
Return on Invested Capital (ROIC)
-62.15%
TTM Avg
-101.35%
3Y Avg
-188.82%
5Y Avg
-152.51%
Market Cap
$112.07M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$110.43M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$114.08M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$108.55M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-45.11%
3Y Avg
-60.38%
5Y Avg
-60.38%
Market Cap
$114.34M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$108.23M
Return on Invested Capital (ROIC)
-73.94%
TTM Avg
-76.71%
3Y Avg
-67.16%
5Y Avg
-152.71%
Market Cap
$114.47M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$114.56M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | $111.35M | -62.15% | -101.35% | -188.82% | -152.51% |
| Caribou Biosciences, Inc. (CRBU)vs › | $112.07M | -87.72% | -74.88% | -52.32% | -62.32% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.43M | -223.06% | -221.51% | -125.15% | -99.68% |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | -19.83% | -23.34% | -19.01% | -18.39% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.55M | -97.99% | -45.11% | -60.38% | -60.38% |
| Genelux Corporation (GNLX)vs › | $114.34M | -192.18% | -186.03% | -161.77% | -220.86% |
| Vivani Medical, Inc. (VANI)vs › | $108.23M | -73.94% | -76.71% | -67.16% | -152.71% |
| Coya Therapeutics, Inc. (COYA)vs › | $114.47M | -0.05% | -44.27% | -81.25% | -78.53% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.56M | -145.10% | -158.49% | -239.94% | -201.97% |
| Apyx Medical Corporation (APYX)vs › | $108.01M | -6.84% | -23.14% | -32.81% | -31.36% |
ROIC
-62.2%
ROE
-66.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -62.15% |
| 2026-03-31 | -78.76% |
| 2025-12-31 | -97.49% |
| 2025-09-30 | -83.66% |
| 2025-06-30 | -184.68% |
| 2025-03-31 | -270.67% |
| 2024-12-31 | -420.38% |
| 2024-09-30 | -103.75% |
| 2024-06-30 | -91.27% |
| 2024-03-31 | -116.62% |
| 2023-09-30 | -496.41% |
| 2023-06-30 | -259.95% |
| 2023-03-31 | -166.64% |
| 2022-09-30 | -332.52% |
| 2022-06-30 | -145.96% |
| 2022-03-31 | -88.03% |
| 2021-12-31 | -53.86% |
| 2021-09-30 | -36.33% |
| 2021-03-31 | -2903.61% |
